Zentalis Pharmaceuticals, Inc. (ZNTL) Capital expenditures 2019–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2019: $352,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $221,000 | -62.1% |
| FY2023 | $583,000 | -77.1% |
| FY2022 | $2.5M | -58.3% |
| FY2021 | $6.1M | +705.7% |
| FY2020 | $758,000 | +115.3% |
| FY2019 | $352,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice